Government Grants
Business Grants
Home Owner Programs
Federal Programs
About Us
HEAL Initiative: Non-addictive Analgesic Therapeutics Development [Small Molecules and Biologics] to Treat Pain (UG3/UH3 Clinical Trial Optional)
Reissue of RFA-NS-20-010:
The purpose of this funding opportunity announcement (FOA) is to support preclinical optimization and development of safe, effective, and non-addictive small molecule and biologic therapeutics to treat pain.
The goal of the program is to accelerate the optimization and development of promising small molecule and biologic hits/leads towards clinical trials.
Applicants must have a promising hit/lead, robust biological rationale for the intended approach, and identified assays for optimization of the agent.
The scope of this program includes optimization and early development activities, IND-enabling studies, and assembly of Investigational New Drug (IND) application.
This is a milestone-driven phased cooperative agreement program involving participation of NIH program staff in the development of the project plan and monitoring of research progress.
The purpose of this funding opportunity announcement (FOA) is to support preclinical optimization and development of safe, effective, and non-addictive small molecule and biologic therapeutics to treat pain.
The goal of the program is to accelerate the optimization and development of promising small molecule and biologic hits/leads towards clinical trials.
Applicants must have a promising hit/lead, robust biological rationale for the intended approach, and identified assays for optimization of the agent.
The scope of this program includes optimization and early development activities, IND-enabling studies, and assembly of Investigational New Drug (IND) application.
This is a milestone-driven phased cooperative agreement program involving participation of NIH program staff in the development of the project plan and monitoring of research progress.
Related Programs
Department of Health and Human Services
Department of Health and Human Services
Department of Health and Human Services
Oral Diseases and Disorders Research
Department of Health and Human ServicesResearch and Training in Complementary and Alternative Medicine
Department of Health and Human ServicesDepartment of Health and Human Services
Drug Abuse and Addiction Research Programs
Department of Health and Human ServicesNIH Office of Research on Women"s Health
Department of Health and Human ServicesArthritis, Musculoskeletal and Skin Diseases Research
Department of Health and Human ServicesDiabetes, Digestive, and Kidney Diseases Extramural Research
Department of Health and Human ServicesExtramural Research Programs in the Neurosciences and Neurological Disorders
Department of Health and Human ServicesChild Health and Human Development Extramural Research
Department of Health and Human ServicesDepartment of Health and Human Services
Department of Health and Human Services
Agency: Department of Health and Human Services
Office: National Institutes of Health
Estimated Funding: $300,000
Office: National Institutes of Health
Estimated Funding: $300,000
Who's Eligible
Relevant Nonprofit Program Categories
Obtain Full Opportunity Text:
http://grants.nih.gov/grants/guide/rfa-files/RFA-NS-21-010.html
Additional Information of Eligibility:
Other Eligible Applicants include the following: Alaska Native and Native Hawaiian Serving Institutions; Asian American Native American Pacific Islander Serving Institutions (AANAPISISs); Eligible Agencies of the Federal Government; Faith-based or Community-based Organizations; Hispanic-serving Institutions; Historically Black Colleges and Universities (HBCUs); Indian/Native American Tribal Governments (Other than Federally Recognized); Non-domestic (non-U.S.) Entities (Foreign Organizations); Regional Organizations; Tribally Controlled Colleges and Universities (TCCUs) ; U. S. Territory or Possession.
Full Opportunity Web Address:
http://grants.nih.gov/grants/guide/rfa-files/RFA-NS-21-010.html
Contact:
Agency Email Description:
If you have any problems linking to this funding announcement, please contact the NIH OER Webmaster
Agency Email:
Date Posted:
2020-09-16
Application Due Date:
Archive Date:
2022-10-13
Social Entrepreneurship
Spotlight
When it Comes to Social Enterprises, Failure is the Best Platform for Innovation
In the world of social enterprises, failure is a cringe-worthy moment nobody wants to talk about. But, social entrepreneurs can benefit from their failures.
Learn How to Identify and Avoid Grant Scams
